GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | 11/6/2026 6:15:34 AM | Small | View | Financials | 10-Q | SEC | 3Q 2026 ending: 9/30/2026 | Assets $511,320,000 | EPS -$0.15 | ||
| Allogene Therapeutics, Inc. (ALLO) | 11/5/2026 4:16:00 PM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $0 | Assets $511,320,000 | EPS -$0.15 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 8/12/2026 4:38:25 PM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $4,640,000 | Assets $550,091,000 | EPS -$0.13 | |
| Allogene Therapeutics, Inc. (ALLO) | 8/12/2026 4:13:26 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $4,640,000 | Assets $550,091,000 | EPS -$0.13 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 5/13/2026 4:16:28 PM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $395,958,000 | EPS -$0.18 | ||
| Allogene Therapeutics, Inc. (ALLO) | 5/13/2026 4:05:05 PM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $395,958,000 | EPS -$0.18 | Export Earnings Model | ||
| Allogene Therapeutics, Inc. (ALLO) | 4/30/2026 6:41:13 PM | View | Proxy | SEC | Y 2025 | ||||||
| Allogene Therapeutics, Inc. (ALLO) | 3/12/2026 4:24:52 PM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $415,905,000 | EPS -$0.87 | ||
| Allogene Therapeutics, Inc. (ALLO) | 3/12/2026 4:08:07 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $0 | Assets $415,905,000 | EPS -$0.17 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 11/6/2025 4:45:30 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $439,771,000 | EPS -$0.19 | ||
| Allogene Therapeutics, Inc. (ALLO) | 11/6/2025 4:33:56 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $0 | Assets $439,771,000 | EPS -$0.19 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 8/13/2025 4:24:35 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $470,593,000 | EPS -$0.23 | ||
| Allogene Therapeutics, Inc. (ALLO) | 8/13/2025 4:12:35 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $0 | Assets $470,593,000 | EPS -$0.23 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 5/13/2025 4:13:50 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $507,982,000 | EPS -$0.28 | ||
| Allogene Therapeutics, Inc. (ALLO) | 5/13/2025 4:08:35 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $0 | Assets $507,982,000 | EPS -$0.28 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 4/30/2025 6:02:09 AM | View | Proxy | SEC | Y 2024 | ||||||
| Allogene Therapeutics, Inc. (ALLO) | 3/13/2025 4:13:25 PM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $22,000 -76.8% | Assets $548,710,000 | EPS -$1.32 | |
| Allogene Therapeutics, Inc. (ALLO) | 3/13/2025 4:04:41 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $0 | Assets $548,710,000 | EPS -$0.28 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 11/7/2024 4:34:29 PM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $589,120,000 | EPS -$0.32 | ||
| Allogene Therapeutics, Inc. (ALLO) | 11/7/2024 4:07:51 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $0 | Assets $589,120,000 | EPS -$0.32 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 8/7/2024 4:20:03 PM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $646,883,000 | EPS -$0.35 | ||
| Allogene Therapeutics, Inc. (ALLO) | 8/7/2024 4:07:32 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $0 | Assets $646,883,000 | EPS -$0.35 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 5/13/2024 4:18:43 PM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $22,000 -26.7% | Assets $586,350,000 | EPS -$0.38 | |
| Allogene Therapeutics, Inc. (ALLO) | 5/13/2024 4:03:16 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $22,000 -26.7% | Assets $586,350,000 | EPS -$0.38 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 4/23/2024 4:37:29 PM | View | Proxy | SEC | Y 2023 | ||||||
| Allogene Therapeutics, Inc. (ALLO) | 3/14/2024 5:09:19 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $95,000 -39.1% | Assets $642,837,000 | EPS -$2.09 | |
| Allogene Therapeutics, Inc. (ALLO) | 3/14/2024 4:18:51 PM | Mid | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Rev: $156,000 -99.9% | Assets $821,579,000 | EPS -$2.38 | |
| Allogene Therapeutics, Inc. (ALLO) | 3/14/2024 4:11:49 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $21,000 -19.2% | Assets $642,837,000 | EPS -$0.51 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 11/2/2023 4:18:08 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $22,000 -18.5% | Assets $713,411,000 | EPS -$0.37 | |
| Allogene Therapeutics, Inc. (ALLO) | 11/2/2023 4:04:42 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $22,000 -18.5% | Assets $713,411,000 | EPS -$0.37 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 8/2/2023 4:20:32 PM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $22,000 -65.6% | Assets $773,007,000 | EPS -$0.54 | |
| Allogene Therapeutics, Inc. (ALLO) | 8/2/2023 4:05:45 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $22,000 -65.6% | Assets $773,007,000 | EPS -$0.54 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 5/3/2023 4:21:15 PM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $30,000 -23.1% | Assets $750,128,000 | EPS -$0.69 | |
| Allogene Therapeutics, Inc. (ALLO) | 5/3/2023 4:06:18 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $30,000 -23.1% | Assets $750,128,000 | EPS -$0.69 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 4/24/2023 4:09:59 PM | View | Proxy | SEC | Y 2022 | ||||||
| Allogene Therapeutics, Inc. (ALLO) | 2/28/2023 4:31:06 PM | Mid | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $156,000 -99.9% | Assets $821,579,000 | EPS -$2.38 | |
| Allogene Therapeutics, Inc. (ALLO) | 2/28/2023 4:08:39 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $26,000 -100.0% | Assets $821,579,000 | EPS -$0.68 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 11/2/2022 4:37:52 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $27,000 -44.9% | Assets $894,477,000 | EPS -$0.59 | |
| Allogene Therapeutics, Inc. (ALLO) | 11/2/2022 4:17:28 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $27,000 -44.9% | Assets $894,477,000 | EPS -$0.59 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 8/11/2022 4:04:27 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $64,000 +45.5% | Assets $955,621,000 | EPS -$0.56 | |
| Allogene Therapeutics, Inc. (ALLO) | 8/9/2022 8:56:03 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $64,000 +45.5% | Assets $955,621,000 | EPS -$0.56 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 5/4/2022 4:31:50 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $39,000 -99.9% | Assets $978,091,000 | EPS -$0.56 | |
| Allogene Therapeutics, Inc. (ALLO) | 5/4/2022 4:19:39 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $39,000 -99.9% | Assets $978,091,000 | EPS -$0.56 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 4/26/2022 4:29:29 PM | View | Proxy | SEC | Y 2021 | ||||||
| Allogene Therapeutics, Inc. (ALLO) | 2/23/2022 4:22:19 PM | Mid | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $114,089,000 | Assets $1,050,828,000 | EPS -$1.34 | |
| Allogene Therapeutics, Inc. (ALLO) | 2/23/2022 4:17:06 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $75,651,000 | Assets $1,050,828,000 | EPS $0.01 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 11/4/2021 4:33:15 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $49,000 | Assets $1,079,246,000 | EPS -$0.57 | |
| Allogene Therapeutics, Inc. (ALLO) | 11/4/2021 4:32:43 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $49,000 | Assets $1,079,246,000 | EPS -$0.57 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 8/4/2021 4:54:32 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $44,000 | Assets $1,126,724,000 | EPS -$0.53 | |
| Allogene Therapeutics, Inc. (ALLO) | 8/4/2021 4:39:51 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $44,000 | Assets $1,126,724,000 | EPS -$0.53 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 5/5/2021 4:33:57 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $38,345,000 | Assets $1,179,044,000 | EPS -$0.25 | |
| Allogene Therapeutics, Inc. (ALLO) | 5/5/2021 4:23:24 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $38,345,000 | Assets $1,179,044,000 | EPS -$0.25 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 4/22/2021 4:29:29 PM | View | Proxy | SEC | Y 2020 | ||||||
| Allogene Therapeutics, Inc. (ALLO) | 2/25/2021 5:12:49 PM | Mid | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $1,227,829,000 | EPS -$2.63 | ||
| Allogene Therapeutics, Inc. (ALLO) | 2/25/2021 4:12:14 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $0 | Assets $1,227,829,000 | EPS -$1.08 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 11/4/2020 8:12:05 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $1,222,500,000 | EPS -$0.52 | ||
| Allogene Therapeutics, Inc. (ALLO) | 11/4/2020 7:38:30 AM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $0 | Assets $1,222,500,000 | EPS -$0.52 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 8/5/2020 7:54:19 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $1,258,544,000 | EPS -$0.53 | ||
| Allogene Therapeutics, Inc. (ALLO) | 8/5/2020 7:37:29 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $0 | Assets $1,258,544,000 | EPS -$0.53 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 5/6/2020 4:25:31 PM | Small | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $688,523,000 | EPS -$0.50 | ||
| Allogene Therapeutics, Inc. (ALLO) | 5/6/2020 7:37:31 AM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $0 | Assets $688,523,000 | EPS -$0.50 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 4/23/2020 4:37:34 PM | View | Proxy | SEC | Y 2019 | ||||||
| Allogene Therapeutics, Inc. (ALLO) | 2/27/2020 4:26:22 PM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $717,802,000 | EPS -$1.83 | ||
| Allogene Therapeutics, Inc. (ALLO) | 2/27/2020 7:31:35 AM | View | Financials | Earnings | SEC | Y 2019 | Rev $0 | Assets $717,802,000 | EPS -$0.59 | Export Earnings Model | |
| Allogene Therapeutics, Inc. (ALLO) | 11/5/2019 4:26:40 PM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $695,544,000 | EPS -$0.50 | ||
| Allogene Therapeutics, Inc. (ALLO) | 11/5/2019 7:33:52 AM | View | Financials | Earnings | SEC | 3Q 2019 | Assets $695,544,000 | EPS -$0.50 | Export Earnings Model | ||
| Allogene Therapeutics, Inc. (ALLO) | 8/7/2019 4:35:55 PM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $733,997,000 | EPS -$0.41 | ||
| Allogene Therapeutics, Inc. (ALLO) | 8/7/2019 7:40:27 AM | View | Financials | Earnings | SEC | 2Q 2019 | Assets $733,997,000 | EPS -$0.41 | Export Earnings Model | ||
| Allogene Therapeutics, Inc. (ALLO) | 5/7/2019 4:36:01 PM | Small | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $749,369,000 | EPS -$0.32 | ||
| Allogene Therapeutics, Inc. (ALLO) | 5/7/2019 8:37:40 AM | View | Financials | Earnings | SEC | 1Q 2019 | Assets $749,369,000 | EPS -$0.32 | Export Earnings Model | ||
| Allogene Therapeutics, Inc. (ALLO) | 4/24/2019 8:03:19 AM | View | Proxy | SEC | Y 2018 | ||||||
| Allogene Therapeutics, Inc. (ALLO) | 3/8/2019 4:25:43 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | ||||
| Allogene Therapeutics, Inc. (ALLO) | 3/8/2019 8:11:24 AM | View | Financials | Earnings | SEC | Y 2018 | Assets $773,855,000 | EPS -$0.37 | Export Earnings Model | ||
| Allogene Therapeutics, Inc. (ALLO) | 11/21/2018 4:46:33 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 |